Three patent applications have now passed procedural hurdles and have been accepted for examination by the USPTO. They are:
Column 1 Column 2 Column 3 0 20190117618 ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS
Column 1 Column 2 Column 3 0 20190117620 CHEMOTHERAPY IMPROVEMENTS
Column 1 Column 2 Column 3 0 20190160004 IMPROVEMENTS IN CANCER TREATMENT
Improvements in Cancer Treatment gives a clear explanation of why rectal administration is the key to making isoflavones work on a consistent basis, as this route bypasses the liver and the gut and therefore avoids conjugation; and why it is essential to dissolve an isoflavone in a hydrophobic or lipophilic base, rather than simply mixing them together.
The international search report states that dissolving idronoxil in the base is an inventive step.
- Forums
- ASX - By Stock
- Patent Update
NOX
noxopharm limited
Add to My Watchlist
3.06%
!
9.5¢

Three patent applications have now passed procedural hurdles and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.5¢ |
Change
-0.003(3.06%) |
Mkt cap ! $27.76M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.5¢ | $570 | 6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47773 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 90000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47773 | 0.093 |
2 | 17198 | 0.092 |
1 | 10989 | 0.091 |
2 | 60888 | 0.090 |
1 | 20000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 90000 | 1 |
0.100 | 47999 | 2 |
0.105 | 31954 | 1 |
0.110 | 89079 | 5 |
0.115 | 55816 | 3 |
Last trade - 13.55pm 15/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online